Search Results
Dr. Goede on the Results from the Phase III CLL11 Trial
Dr. Goede Discusses Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia
ASCO 2013 - Dr. Valentin Goede, CLL11 Trial
Improved OS with obinutuzumab in the CLL11 study
Dr. Valentin Goede on Obinutuzumab Versus Rituximab in CLL
Obinutuzumab/chlorambucil gives OS benefit over rituximab in frontline CLL
Dr. Wierda Discusses the CLL11 Trial
Dr. Sehn Discusses the GAUSS Obinutuzumab Trial
Dr. Jennifer Brown Discusses Final Stage 2 Results of the CLL11 Trial
EHA 2013: Adding obinutuzumab or rituximab to chlorambucil improves chronic lymphocytic leukaemia
Results of Phase II trial to assess the efficacy and safety of idelalisib
The latest CLL treatments and therapies with Dr Jan Burger
